| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/09/2014 | US8829166 Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
| 09/09/2014 | US8829160 Antibody biomarker specific for mitotic cells and related methods |
| 09/09/2014 | US8829159 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
| 09/09/2014 | US8829158 Peptides, derivatives and analogs thereof, and methods of using same |
| 09/09/2014 | US8829157 Process for the synthesis of cyclic heptapeptide |
| 09/09/2014 | US8829018 Method of restoring the incretin effect |
| 09/09/2014 | US8828975 Phosphate-containing nanoparticle delivery vehicle |
| 09/09/2014 | US8828974 Substituted propane phosphinic acid derivatives |
| 09/09/2014 | US8828971 Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828957 Methods for generating immunity to antigen |
| 09/09/2014 | US8828949 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 09/09/2014 | US8828948 Method of treating a patient having an autoimmune disorder by administering BAFFR polypeptide |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828946 Composition comprising interleukin-1 receptor antagonist and corticosteroid |
| 09/09/2014 | US8828945 Inactivation of smooth muscle tissue |
| 09/09/2014 | US8828942 Means for treating synucleinopathies |
| 09/09/2014 | US8828941 Composition and method for the treatment or prevention of spinal disorders |
| 09/09/2014 | US8828940 Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands |
| 09/09/2014 | US8828939 Modified vitamin K dependent polypeptides |
| 09/09/2014 | US8828937 Bone morphogenetic protein 2 (BMP2) variants with reduced BMP antagonist sensitivity |
| 09/09/2014 | US8828936 Therapeutic use of SCGB3A2 |
| 09/09/2014 | US8828935 Agent for suppressing elevation of blood triglyceride concentration |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828933 Mutant tat proteins and uses thereof |
| 09/09/2014 | US8828932 Bifunctional molecules for inactivating HIV and blocking HIV entry |
| 09/09/2014 | US8828931 Bifunctional molecules for inhibiting HIV entry |
| 09/09/2014 | US8828930 Hepatitis C virus NS3 protease inhibitors |
| 09/09/2014 | US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof |
| 09/09/2014 | US8828928 Amphiphilic peptides and peptide particles |
| 09/09/2014 | US8828927 Elastin digest compositions and methods utilizing same |
| 09/09/2014 | US8828926 Uses of natriuretic peptide constructs |
| 09/09/2014 | US8828925 Etoposide and doxorubicin conjugates for drug delivery |
| 09/09/2014 | US8828924 Methods of treating a diabetic embryopathy |
| 09/09/2014 | US8828923 Insulin derivatives |
| 09/09/2014 | US8828922 HSP therapy in conjunction with a low antigenicity diet |
| 09/09/2014 | US8828724 Method for preparing cells for engraftment |
| 09/09/2014 | US8828723 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC |
| 09/09/2014 | US8828698 Immobilized angiogenin mixtures and uses thereof |
| 09/09/2014 | US8828685 Monomeric forms of human aminoacyl-t-RNA synthetases having non-canonical biological activities |
| 09/09/2014 | US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA |
| 09/09/2014 | US8828668 Markers for determination of patient responsiveness |
| 09/09/2014 | US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor |
| 09/09/2014 | US8828413 Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| 09/09/2014 | US8828404 Vaccine and method for treatment of neurodegenerative diseases |
| 09/09/2014 | US8828403 Anti-tumor immunotherapy |
| 09/09/2014 | US8828394 Methods for treating IgE-mediated disorder |
| 09/09/2014 | US8828389 Methods of diagnosing ALS |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/09/2014 | US8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
| 09/09/2014 | US8828380 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 09/09/2014 | US8828378 Targeted vectors for cancer immunotherapy |
| 09/09/2014 | US8828375 Expansion of haemopoietic precursors |
| 09/09/2014 | US8828358 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| 09/09/2014 | CA2693154C Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 09/09/2014 | CA2674908C Tri-demethylation-capable protein complex, method of its preparation and its use |
| 09/09/2014 | CA2655933C Polynucleotides and polypeptide sequences involved in cancer |
| 09/09/2014 | CA2638828C Immunomodulatory and anti-tumor peptides derived from lalf |
| 09/09/2014 | CA2634760C Compositions and methods for producing a composition |
| 09/09/2014 | CA2477854C Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions |
| 09/09/2014 | CA2473733C Cytokine receptor zcytor17 multimers |
| 09/09/2014 | CA2400256C Compositions useful for regulating parkin gene activity |
| 09/09/2014 | CA2395585C Chimeric natriuretic peptides |
| 09/09/2014 | CA2284078C A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/09/2014 | CA2258721C Chimeric heteromultimer adhesins |
| 09/04/2014 | WO2014134562A1 Methods for the treatment of mitochondrial disease |
| 09/04/2014 | WO2014134554A1 Methods and compositions for the prevention or treatment of barth syndrome |
| 09/04/2014 | WO2014134419A1 Use of ikach blockers for the treatment of cardiac diseases |
| 09/04/2014 | WO2014134251A1 Pharmaceutical compositions |
| 09/04/2014 | WO2014134084A2 Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy |
| 09/04/2014 | WO2014134038A1 Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration |
| 09/04/2014 | WO2014133541A2 Method and system for treatment of cardiovascular disorders |
| 09/04/2014 | WO2014132179A1 Preparation of stabilized catalase enzymes with a surfactant |
| 09/04/2014 | WO2014132100A1 Mobilizing agents and uses therefor |
| 09/04/2014 | WO2014132084A1 Non-immunosuppressive cyclosporin derivatives as antiviral agents |
| 09/04/2014 | WO2014132072A1 Csf1 therapeutics |
| 09/04/2014 | WO2014131877A1 Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cells |
| 09/04/2014 | WO2014131865A1 Therapeutic agent for amniotic fluid embolism |
| 09/04/2014 | WO2014131856A1 Treatment of neonatal alloimmune thrombocytopenia |
| 09/04/2014 | WO2014131815A1 Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role |
| 09/04/2014 | WO2014131122A1 Formulations of growth hormone releasing factor (grf) molecules with improved stability |
| 09/04/2014 | WO2014109725A3 Use of glycyl glutamine against depression |
| 09/04/2014 | WO2014106459A3 Method for treating tumor by using recombinant interferon with changed spatial configuration |
| 09/04/2014 | WO2014081702A4 Synthetic linear apelin mimetics for the treatment of heart failure |
| 09/04/2014 | WO2014066392A3 Compositions and methods for regulating arterial tone |
| 09/04/2014 | WO2013179264A4 Compounds modulating astrocytic release of substances through connexins and pannexins and treatment of psychiatric disorders |
| 09/04/2014 | WO2013109342A8 Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| 09/04/2014 | US20140249092 Cyclosporin analog formulations |
| 09/04/2014 | US20140249090 Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders |
| 09/04/2014 | US20140249088 Methods of treating neuropathic pain |
| 09/04/2014 | US20140249087 Use of hemopexin to sequester hemoglobin |
| 09/04/2014 | US20140249085 Calcitonin products and therapies for treating inflammatory or degenerative diseases |
| 09/04/2014 | US20140249084 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week in a unit dose of 100 to 200 units |
| 09/04/2014 | US20140249081 Nanoparticle peptide compositions |
| 09/04/2014 | US20140249080 Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation |
| 09/04/2014 | US20140249079 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anonic polymer |
| 09/04/2014 | US20140249078 Whey protein micelles against muscle atrophy and sarcopenia |
| 09/04/2014 | US20140249077 Gel compositions |
| 09/04/2014 | US20140249075 Methods for reducing cd36 expression |
| 09/04/2014 | US20140249071 Enhanced anabolic cytokine production and delivery system |